The Effect of Spinal Column Flexion on Unilaterality of Spinal Anesthesia

July 30, 2024 updated by: Ankara City Hospital Bilkent
The effect of two different positions on spinal anesthesia in hip fracture surgery

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

One of the more common reasons for hospitalization in affluent nations is femoral fractures. Postpartum mortality and morbidity rates for femur fractures are significant. Mortality rates range from 5% to 8% at the time of initial admission and from 14% to 36% throughout the first year. Age-related mortality rates are rising. Surgery is necessary for femur fractures, and spinal anesthesia is frequently the recommended anaesthetic approach.

After spinal anesthesia, hypotension is frequently seen as a result of sympathetic block and a reduction in systemic vascular resistance. The frequency of hypotension rises as the level of spinal anesthetic block increases, especially in older people. It has been demonstrated that hypotension is connected with an increased mortality rate.

Preoperative fluid administration to reduce hypotension loading, lateral decubitus anesthesia posture, and spinal anesthetic dose reduction techniques have all been used.

There are several methods to enhance the quality of the block in spinal anesthesia, including local changes to the anesthetic's baricity, volume, infusion rate, and lateral decubitus position. There are numerous variables, including residency time and spinal needle type. The influence of alterations in the spinal cord inside the vertebral column on body position in the literature was examined using lumbar MR imaging. Based on these research, it was intended to study the role that alterations in spinal anesthesia played in the applications of spinal anesthesia. spinal column Hemiblock is thought to result in more stable hemodynamics during anesthesia. Studies can be found. The goal of this study is to administer semispinal anesthesia while doing spinal anesthesia. To ensure that the underlying spinal cord is impacted by the local anesthetic and to monitor the impact on unilateral block development and hemodynamic parameters, the colon is flexed and squeezed to the surgery side and anterior area of the spinal cord.

The study will take unilateral femoral fracture surgery into account. Both groups will be given spinal anesthesia in the study's lateral

First, Group F will keep the spinal cord flexed for 10 minutes while Group N will preserve the spinal cord's normal position in lateral decubitus. The quality of the ensuing block will be compared between the two groups. When spinal anesthetic is being used, patients may feel excruciating pain while in the prescribed position.

To lessen positional pain and the impact of hemodynamic deterioration brought on by pain during spinal anesthesia, pericapsular nerve group (PENG) block will be used.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ASA 1-2-3
  • Hip fracture
  • 18-85 Age
  • BMI: 18-40

Exclusion Criteria:

  • ASA score of 4 and above
  • Left ventricular ejection fraction below 40%
  • Severe aortic valve stenosis
  • Obesity (BMI >40)
  • Presence of cardiac arrhythmia
  • Having peripheral vascular disease
  • Failure of spinal block
  • Bleeding diathesis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group F
the lateral decubitus position, Group F will keep the spinal cord flexed for 10 minutes,
7.5 mg Bupivacaine hydrochloride (0.5% heavy Marcaine) will be used on spinal anesthesia. (each group)
Other: Group N
the lateral decubitus position, Group N will keep the natural position of the spinal cord in lateral decubitus for 10 minutes,
7.5 mg Bupivacaine hydrochloride (0.5% heavy Marcaine) will be used on spinal anesthesia. (each group)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hemodynamic change
Time Frame: Within 5 minutes after anesthesia
Heart rate
Within 5 minutes after anesthesia
Hemodynamic change
Time Frame: Within 10 minutes after anesthesia
Heart rate
Within 10 minutes after anesthesia
Hemodynamic change
Time Frame: Within 3 minutes after anesthesia
Heart rate
Within 3 minutes after anesthesia
Hemodynamic change blockade to the dependent lower limb in flexed and extended spine position.
Time Frame: 15 minutes
Heart rate
15 minutes
Hemodynamic change blockade to the dependent lower limb in flexed and extended spine position.
Time Frame: 20 minutes after anesthesia
Heart rate
20 minutes after anesthesia
Hemodynamic change blockade to the dependent lower limb in flexed and extended spine position.
Time Frame: 30 minutes after anesthesia
Heart rate
30 minutes after anesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare the efficacy, duration of motor block until return to normal function in the non-operated leg after the start of injection, of bupivacaine 7.5 mg/ml when used for spinal anaesthesia in patients undergoing unilateral lower
Time Frame: 10 minutes after anesthesia
bromage score
10 minutes after anesthesia

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare the efficacy of bupivacaine 7.5 mg/ml in the duration of sensory block at dermatome T10 level
Time Frame: Within 1 minutes after anesthesia
sensory block time
Within 1 minutes after anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mehmet Sahap, Ankara City Hospital Bilkent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2024

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

January 31, 2024

First Submitted That Met QC Criteria

February 27, 2024

First Posted (Actual)

March 5, 2024

Study Record Updates

Last Update Posted (Actual)

July 31, 2024

Last Update Submitted That Met QC Criteria

July 30, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

only results

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Bupivacain

Subscribe